ATM is a PI 3-kinase involved in DNA double-strand break repair. ATM deficiency leads to ataxia-telangiectasia (A-T), a syndrome of cancer susceptibility, hypersensitivity to ionizing radiation, immune deficiency, and sterility [1, 2]-phenotypes that can straightforwardly be attributed to a defective response to DNA damage. Yet patients with A-T also suffer from ataxia, speech defects, and abnormal body movements [3-5]-neurological phenotypes whose origins remain largely unexplained. Compounding the discordance, Atm mutations in mouse interfere with DNA repair but have only mild neurological symptoms [6] [7] [8] [9] , suggesting that the link between DNA damage and the death of neurons can be broken [10] [11] [12] . We find that in neurons, ATM protein has a substantial cytoplasmic distribution. We show that in Atm tm1Awb mice, hippocampal long-term potentiation is significantly reduced, as is the rate of spontaneous vesicular dye release, suggesting a functional importance of cytoplasmic ATM. In the cytoplasm, ATM forms a complex with two synaptic vesicle proteins, VAMP2 and synapsin-I, both of which must be phosphorylated to bind ATM. Also, cytoplasmic ATM physically associates with the homologous PI 3-kinase, ATR. The neurological symptoms of ataxiatelangiectasia may thus result from defective nonnuclear functions of ATM not associated with DNA repair.
Results

ATM Distributes in Neuronal Cytoplasm and Fails to Respond to DNA Damage
ATM is best known for its critical role in the DNA damage response where, after autophosphorylation on serine 1981 (S1981), the ATM dimer dissociates into two catalytically active monomers [13] . Although ATM is a predominantly nuclear protein, studies have shown significant amounts of cytoplasmic ATM protein in neurons, the function of which has not been completely identified [14] [15] [16] [17] [18] . We performed subcellular fractionations of tissue extracts from mouse brain, spleen, and thymus ( Figure 1A ). All three tissues had nuclear ATM (lanes 4-6), whereas in spleen and thymus, cytoplasmic ATM was nearly undetectable (lanes 2 and 3). By contrast, in brain tissue, cultured neurons, or N2a cells ( Figure 1C , lanes 1 and 2), significant quantities of cytoplasmic ATM were present. Antibody specificity was confirmed by the absence of a band in Atm tm1Awb tissues (see Figure S1C Figure 1Dc ). Further, in NIH 3T3 cells (Figure 1Df ), GFP-ATM was overwhelmingly nuclear. Finally, ATM could be found in association with synaptic vesicles and synaptic membranes in synaptosomal fractions from mouse brain ( Figure 1E ). Thus, four independent lines of evidence support the existence of neuronal cytoplasmic ATM.
The neuron-specific occurrence of cytoplasmic ATM suggests a function distinct from its role in the DNA damage response. If primary neuronal cultures are exposed to 5 Gy of radiation, the phospho-S1981-ATM epitope appears in the nuclei of neurons or N2a cells as reported previously [19] , but not in the cytoplasm ( Figure 1F ). These results were verified with etoposide ( Figure 1G ; Figure S2 ) and in vivo with ionizing radiation ( Figure S3A ). ATM activation in the nucleus was demonstrated by the enhanced phosphorylation of two ATM targets, p53 and Chk2 ( Figure S3B ). Thus, neither irradiation nor topoisomerase inhibitors activate cytoplasmic ATM, suggesting that its function is unrelated to the DNA damage response.
ATM Deficiency Causes Dysfunction of Synaptic Vesicle Cycling and Long-Term Potentiation
The cytoplasmic and/or synaptosomal presence of ATM in neurons prompted us to ask whether ATM might play a role in synaptic function. We recorded from in vitro slices of adult wild-type and Atm tm1Awb hippocampus but found no deficit in baseline synaptic transmission. Both genotypes had similar input-output curves (Figure 2A) , although there was a tendency for the mutants to show a plateau in responsiveness at lower stimulus currents than wild-type mice. We next tested the consequences of ATM deficiency on long-term potentiation (LTP) at the Schaffer collateral-CA1 synapse. Examination of theta burst stimulation (TBS)-induced LTP revealed that Atm tm1Awb mice have a considerable deficit as compared to wild-type animals ( Figure 2B ). In control mice, TBS produced a maintained elevation in synaptic strength; the same stimulation protocol produced only a modest long-term increase in Atm tm1Awb mice ( Figure 2B ). Previous studies indicate a defect in exocytosis in lymphocytes of ataxia-telangiectasia (A-T) patients [20] . This led us to question whether a defect in vesicle recycling might occur in Atm mutant neurons. We monitored FM4-64 dye uptake and release from cultured neurons derived from either wild-type or Atm tm1Awb mice. There was no significant difference in FM4-64 dye uptake between Atm tm1Awb and wild-type neurons or wild-type neurons treated with RNA interference (RNAi) (data not shown). By contrast, spontaneous dye release was significantly slower in Atm tm1Awb and Atm small interfering RNA (siRNA)-treated cultures than in wildtype, untreated dishes ( Figure 2C ; Movies S1-S3). Thus, in the absence of ATM, spontaneous vesicle release is reduced in culture, and the ability to establish and maintain LTP is significantly impaired.
*Correspondence: herrup@biology.rutgers.edu VAMP2 and Synapsin-I Are Novel Binding Partners of Cytoplasmic ATM We sought to determine the mechanistic basis of these functional deficits. Recently, hundreds of potential ATM/ATR targets have been identified [21] . In light of our findings, two proteins from this list seemed especially noteworthy: VAMP2 and synapsin-I. Both are vesicle proteins that are involved in vesicle trafficking and release. VAMP2 (synaptobrevin) forms a central part of the soluble NSF attachment protein receptor (SNARE) complex that mediates synaptic vesicle fusion with the cell membrane during neurotransmitter release. By immunocytochemistry, ATM partially colocalized with VAMP2 in cultured neurons ( Figure 3A ). This association was confirmed by coimmunoprecipitation with antibody to either ATM or VAMP2 from protein extracts of adult mouse brain ( Figure 3B ). Having demonstrated the physical association of VAMP2 and ATM, we immunoprecipitated VAMP2 from cytoplasmic fractions of mouse neocortex and cerebellum and examined the precipitates on western blots with an antibody against [S/T]Q-phosphorylated sites-the canonical ATM/ ATR target sequence. A strong band of staining was found ( Figure 3C ). The amino acid sequence of VAMP2 revealed two potential ATM/ATR phosphorylation sites: T35 and S75. We constructed nonphosphorylatable alanine substitution mutants at these sites and expressed them as FLAG-tagged derivatives in N2a cells, which we then differentiated with dibutyryl-cAMP. Blots of FLAG immunoprecipitates probed with either phospho-[S/T]Q or a specific phospho-T35-VAMP2 antibody (P-T35) revealed that T35 is significantly phosphorylated in normal neuroblastoma cells ( Figure 3D ). We observed that blocking T35-VAMP2 phosphorylation had two significant consequences. First, immunoprecipitation with ATM antibody revealed that ATM does not bind to the T35A-VAMP2 mutant, suggesting that ATM binds primarily to the phosphorylated form of VAMP2 ( Figure 3D ). Second, overexpression of the T35A-VAMP2 mutant, but not the S75A mutant or wild-type VAMP2, in N2a cells was associated with a decrease in the rate of FM4-64 dye release from differentiated N2a cells ( Figure S4 ). Thus, phosphorylation of VAMP2 at T35 induces ATM binding and leads to a change in neuronal function.
Synapsin-I is an abundant neuronal phosphoprotein that is associated with synaptic vesicles [22] . Synapsin-I/ATM coimmunoprecipitations revealed that they are physically associated ( Figure 3E ). To identify the synapsin-I kinase, we immunoprecipitated synapsin-I from wild-type or Atm tm1Awb brain and probed with the [S/T]Q antibody ( Figure 3F ). In the mutant, immunoreactivity for the [S/T]Q antibody was reduced to nearly undetectable levels. Similar results were found in primary cultures after Atm siRNA introduction ( Figure 4A ). Serine 656 of synapsin-I is a strong theoretical candidate for an ATM/ATR phosphorylation target, a prediction we confirmed by site-directed mutagenesis. Furthermore, the nonphosphorylatable S656A synapsin-I mutant could no longer pull down ATM as efficiently as wild-type ( Figure 3G ). As with VAMP2, blocking synapsin-I phosphorylation had significant functional consequences. Normally, synapsin-I and ATM partially colocalize in cultured cortical neurons where they are found in a punctate pattern along the neurites ( Figure 3H ). In addition to inhibition of ATM binding, the subcellular distribution of both synapsin-I and ATM was altered when S656 phosphorylation was blocked. Coexpression of an mCherry-tagged wild-type synapsin-I with GFP-tagged ATM showed a number of puncta where the two proteins colocalized ( Figure S5 ). By contrast, when synapsin-I carries the S656A mutation, the colocalization with ATM is reduced.
Cytoplasmic ATM and ATR Physically Link VAMP2 and Synapsin-I Having identified ATM as the source of S656 synapsin-I phosphorylation, we next sought to determine the identity of the VAMP2 kinase. Proteins were immunoprecipitated from primary cortical neurons that had been treated with ATM siRNA. Whereas synapsin-I [S/T]Q reactivity was largely blocked by ATM knockdown, [S/T]Q staining of VAMP2 was only slightly reduced ( Figure 4B) . A similar result was found when VAMP2 was immunoprecipitated from Atm tm1Awb brain ( Figure 3G ). Thus, it is unlikely that ATM is a major VAMP2 kinase. We next asked whether ATR, a closely related member of the PI 3-kinase family, might be involved. Application of Atr RNAi all but eliminated the phospho-[S/T]Q and phospho-T35 reactivity of VAMP2 immunoprecipitates and immunostaining of primary neurons (Figures 4B and 4C ; Figures S6 and S7A ), pointing to ATR as the predominant VAMP2 PI 3-kinase. There would thus appear to be a reciprocal relationship among the four proteins, with VAMP2 relying on ATR and synapsin-I relying on ATM as a PI 3-kinase.
Its participation in the phosphorylation of VAMP2 suggested that ATR might also be a VAMP2 binding partner. Immunostaining of brain tissue or cultured neurons demonstrated that ATR has a significant cytoplasmic distribution (Figures 4Da-4Dc) ; the distribution of exogenous GFP-ATR suggested a similar conclusion (Figure 4Dd ). Further, synaptosomal preparations contained ATR in the same fractions as ATM ( Figure 1E ). ATR physically associates with VAMP2 and synapsin-I, because antibodies to ATR pulled down both synaptic proteins. Reverse immunoprecipitations were also successful ( Figure 4E ). These multiple interactions led us to ask whether all of the proteins coexisted in a single complex. VAMP2 can immunoprecipitate synapsin-I from synaptosomal preparations of cultured cortical neurons, and the reverse immunoprecipitation confirmed the synapsin-I/VAMP2 association ( Figure 4F ). Yet when Atm siRNA was used to block the synthesis of ATM in the cultured neurons, VAMP2 and synapsin-I failed to immunoprecipitate each other ( Figure 4F ; Figure S7B ). This is strong evidence that ATM acts as a physical link between VAMP2 and synapsin-I. We next asked whether ATM and ATR were associated with each other. We coexpressed ATM and ATR, each with a different epitope tag, in N2a cells. We performed immunoprecipitations with one of the epitope tags and did western blots with an antibody to the other epitope as probe. A strong band of staining was found in cytoplasmic but not nuclear fractions ( Figure S8 ). Reversing the epitope tags produced a similar result. This suggests that the ATM and ATR proteins do indeed interact, but that their physical association in neurons occurs primarily in the cytoplasm.
Discussion
Neurons and neuronal cell lines appear to be unique in that a substantial fraction of their ATM protein is cytoplasmic, a conclusion supported by three different lines of evidence: subcellular fractionation, immunocytochemistry, and the distribution of an exogenous GFP-ATM fusion protein. The prominence of this cytoplasmic component is cell type specific, because neither spleen, thymus, nor cell lines of , red), spontaneous release kinetics are slowed compared to wild-type (blue). Whereas 60% of the FM4-64 dye is lost after 25 min from wild-type cells, siRNA-treated or Atm tm1Awb neurons lose only 30% of their dye in the same period of time (n = 6, p < 0.01). Graphs represent averages of three independent experiments. Error bars represent standard deviation (SD).
nonneuronal origin have significant amounts of ATM outside of their nucleus.
We postulate that this nonnuclear ATM is different in its function as well as in its location. The biochemical and physical relationships among ATM, ATR, VAMP2, and synapsin-I, coupled with the defects in LTP and spontaneous dye release observed in ATM-deficient neurons, are strong evidence that cytoplasmic ATM plays cellular roles in neurons that are unrelated to the DNA damage response. Cytoplasmic ATM shows no evidence of activation as assessed by phosphorylation at S1981. Yet others have speculated that ATM kinase activity unrelated to the phosphorylation of S1981 exists [23, 24] , and the ATM-dependent phosphorylation of synapsin-I at S656 would tend to support this suggestion.
Both VAMP2 and synapsin-I are best known for their roles in the presynaptic nerve terminal, and we have shown that ATM protein is found in synaptosomal preparations. It is unlikely, however, that the function of cytoplasmic ATM is restricted to presynaptic terminals, because immunocytochemistry also reveals robust staining in the cell soma and dendrites. The actions of cytoplasmic ATM and ATR appear to be symmetrical. We show that all four proteins can physically associate with one another in the cytoplasm, but, whereas the ATM kinase targets synapsin-I, ATR targets VAMP2. The involvement of the ATR kinase in the cytoplasmic function of ATM is intriguing, because a partial deficiency of ATR leads to devastating neurological consequences [25] .
The subtle nature of the synaptic changes in ATM-deficient neurons suggests a regulatory role for cytoplasmic ATM in neuronal activity rather than a central function in synaptic connectivity. It seems likely that either phosphorylation of VAMP2 or its binding to ATM would sterically interfere with its normal function in vesicle docking and fusion. Perhaps ATM holds a pool of VAMP2 and/or synapsin-I in reserve to be released as needed. Alternatively, ATM may assist in the transport of VAMP2 and synapsin-I by keeping them in a protected state, consistent with the distribution of the nonphosphorylatable proteins in cultured neurons.
In the aggregate, these novel associations of ATM with synaptic function provide new and unexpected explanations for the severe neurological symptoms in children with A-T and possibly open new avenues of intervention specifically related to cytoplasmic ATM function [26] . It would appear that in conjunction with the cell-cycle-related cell death [27] , A-T neurons are subject to a synaptic dystrophy that can only exacerbate the damage caused by cell loss.
Experimental Procedures
Introduction of siRNA in Primary Cultural Neurons siRNA duplexes against mouse Atm and Atr were purchased from Integrated DNA Technologies. We used mainly siRNA in our study; the Atm sense strand was 5 0 -GGAGCAUGCUCUAAGGACATT-3 0 , and the Atr sense strand was 5 0 -CUCCAAAGCACCACUGAAUTT-3 0 . Primary cultures of mouse embryonic neurons were transfected with siRNA plus Lipofectamine 2000, first at 5 days in vitro (DIV) and again at 9 DIV. Samples were mainly collected between 10 and 14 DIV.
FM4-64-Tracking Vesicle Recycling
Dissociated cortical neurons were cultured in vitro for 14 days and then incubated in 10 mM FM4-64 (Molecular Probes). Dye uptake was induced by exposing the neurons to Tyrode's solution containing 47 mM KCl and 2 mM CaCl 2 for 90 s at room temperature. Fluorescence images of FM4-64-labeled vesicles were captured after 15 min of perfusion with dye-free solution. For live imaging, one frame was captured every 10 s over a total analysis period of 1 hr.
Field Potential Recording
Extracellular recordings of field excitatory postsynaptic potentials (fEPSPs) were made with artificial cerebrospinal fluid (ACSF)-filled glass electrodes (5-10 mm tip diameter). Test stimuli (0.1 ms) were delivered with a bipolar platinum/iridium stimulating electrode at 1 min intervals, except for specialized protocols that elicited changes in synaptic strength (see below). For recordings of CA1 activation by Schaffer collateral stimulation, recording and stimulating electrodes were both placed in stratum radiatum. Each experiment was begun by obtaining input-output relationships to establish the strength of baseline synaptic transmission. A Grass S8800 stimulator connected to a Grass PSIU6 photoelectric stimulus isolation unit was used to deliver a series of increasing-intensity constant-current pulses. Current magnitude was adjusted to elicit responses ranging from just suprathreshold to near maximal. Following this, stimulus intensity was adjusted to evoke fEPSPs 30%-40% of maximum, typically 30-40 mA. To elicit LTP, TBS was used. A single TBS consisted of 12 bursts of four 100 Hz pulses spaced 200 ms apart. Response magnitude was quantified with the slope of the field potential.
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